Indmed Pharmaceuticals Limited

Indmed Pharmaceuticals Limited - trading in Indore, Madhya Pradesh, India. Directors, charges & compliance details.
CIN U02423MP2005PLC017452 Incorporated 18 March 2005 ROC Gwalior HQ Indore, Madhya Pradesh, India
Struck Off Public Limited Company trading
Revenue · FY 2018
₹2.01 Lakh
▼ 78% YoY
Net loss · FY 2018
₹1.14 Lakh
Net margin -56.7%
EBITDA · FY 2018
-₹81,695
EBITDA margin -40.6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
21 yrs
Est. 2005
Directors on board
3
As per MCA filings
GST registrations
1
None active

About Indmed Pharmaceuticals Limited

Data last updated:

Indmed Pharmaceuticals Limited was a public limited company based in Indore, Madhya Pradesh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 18 March 2005.

The company was registered with the Registrar of Companies (ROC), Gwalior, under CIN U02423MP2005PLC017452. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors including Neeraj Manocha and Sifti Manocha.

Its last annual general meeting (AGM) was held on 25 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Annex 100 Sda Compound Lasudiya Mori Dewas Naka, Indore, Madhya Pradesh, India – 452001.

As per the financials filed for FY 2018, the company reported a revenue of ₹2.01 Lakh, a decline of 78% compared to the previous year. For the same year it recorded a net loss of ₹1.14 Lakh (net margin -56.7%) and EBITDA of -₹81,695 (EBITDA margin -40.6%). Revenue has declined at a compounded annual rate (CAGR) of 50% over three years.

Company details

CIN U02423MP2005PLC017452
Registration Number 017452
Incorporation Date 18 March 2005
ROC Gwalior
Listing Status Unlisted
Company Status Struck Off
Compliance Status Active Compliant

Contact details

Indmed Pharmaceuticals Limited's registered office is in Indore, Madhya Pradesh.

  • Registered Address
    Annex 100 Sda Compound Lasudiya Mori Dewas Naka, Indore, Madhya Pradesh, India – 452001
  • Industry
    Trading, Other Wholesale, Wholesale
Comprehensive company report
Indmed Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Indmed Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Indmed Pharmaceuticals Limited, buy the company report.

Financials of Indmed Pharmaceuticals Limited

FY 2018 filings available

Indmed Pharmaceuticals Limited reported revenue of ₹2.01 Lakh (down 78% YoY) for FY 2018.

Revenue · FY 2018
₹2.01 Lakh ▼ 78%
Net loss · FY 2018
₹1.14 Lakh margin -56.7%
EBITDA · FY 2018
-₹81,695 margin -40.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 78%
3 years · compounded
▼ 50%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▼ 57%

Revenue has declined at a compounded annual rate (CAGR) of 50% over three years, including a 78% fall in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹81,695
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.14 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin-40.6%
Net Profit Margin-56.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Indmed Pharmaceuticals Limited, buy the company report.

Board of directors of Indmed Pharmaceuticals Limited

Indmed Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Sifti ManochaAdditional Director11 Jun 20197 Years 5 MonthsAs last reported
Neeraj ManochaDirector22 Mar 200521 Years 7 MonthsAs last reported
Kunal DangAdditional Director11 Jun 20197 Years 5 MonthsAs last reported

Peer comparison

Indmed Pharmaceuticals Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pipal Pharmaceuticals Private Limited₹2.05 Lakh (FY 2018)-78.0%Patna, Bihar, India
Viprans Drug and Pharmaceuticals Private Limited₹2.04 Lakh (FY 2022)121.0%Bhopal, Madhya Pradesh, India
As Pharmaceuticals (OPC) Private Limited₹2.04 Lakh (FY 2021)0.0%Varanasi, Uttar Pradesh, India
Indmed Pharmaceuticals Limitedthis company₹2.01 Lakh (FY 2018)-₹1.14 Lakh-56.7%-78.0%Indore, Madhya Pradesh, India
Sandex Pharmaceuticals Private Limited₹2 Lakh (FY 2025)Karunagappally, Kerala, India

To see the full peer comparison of Indmed Pharmaceuticals Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Indmed Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Indmed Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Indmed Pharmaceuticals Limited, buy the company report.

Recent activity

Indmed Pharmaceuticals Limited has 5 board changes on record since 2005: 3 appointments and 2 cessations. The latest: Chandra Prakash Manocha ceased to be Director on 11 Jun 2019.

Ceased
Chandra Prakash Manocha ceased to be Director.
Appointed
Kunal Dang was appointed as Additional Director.
Ceased
Rita Manocha ceased to be Director.
Appointed
Sifti Manocha was appointed as Additional Director.
AGM
Indmed Pharmaceuticals Limited last Annual general meeting of members was held on 25 Sep 2018 as per latest MCA records.
Filing
Indmed Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Gwalior.
Appointed
Neeraj Manocha was appointed as Director.
Incorporation
18 Mar 2005
Indmed Pharmaceuticals Limited was registered on 18 Mar 2005 with Roc Gwalior & aged 21 years 8 months as per MCA records.

Frequently asked questions

Indmed Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Indmed Pharmaceuticals was a public limited company based in Indore, Madhya Pradesh, India. The company worked in other wholesale, within the trading industry. It was incorporated on 18 March 2005 and is registered under CIN U02423MP2005PLC017452. The company has been struck off by the Registrar of Companies and is no longer operational.

Indmed Pharmaceuticals had 3 directors:

The CIN (Corporate Identification Number) of Indmed Pharmaceuticals is U02423MP2005PLC017452. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Indmed Pharmaceuticals is at Annex 100 Sda Compound Lasudiya Mori Dewas Naka, Indore, Madhya Pradesh, India – 452001.

Indmed Pharmaceuticals was incorporated on 18 March 2005. It is registered with the Registrar of Companies, Gwalior.

The latest financial statements of Indmed Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 25 September 2018. Year-wise statements from 2015 are in the company report.

No. Indmed Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.

Indmed Pharmaceuticals operated in the trading industry, in the other wholesale segment. It worked in this industry before it was struck off.

The peers of Indmed Pharmaceuticals by revenue are Pipal Pharmaceuticals Private Limited, Viprans Drug and Pharmaceuticals Private Limited, As Pharmaceuticals (OPC) Private Limited, Sandex Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Chandra Prakash Manocha ceased to be Director on 11 Jun 2019. Kunal Dang was appointed as Additional Director on 11 Jun 2019. Rita Manocha ceased to be Director on 11 Jun 2019. Indmed Pharmaceuticals has 5 board changes on record in total.